Stem Cell Fusion Confusion

5-Prime | Stem Cell Fusion Confusion 1. How did the idea of transdifferentiation arise? In the late 1990s, sex-mismatched transplants and experiments with rodents revealed apparent transgressions of embryonic cell fates. Bone marrow cells could yield liver, muscle, neuron, and endothelium, while neurons could give rise to blood, and hepatocytes to pancreatic beta cells. Stem cells seemed to home in on injury sites, producing daughters that dedifferentiate and redifferentiate into exactly

Written byRicki Lewis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

1. How did the idea of transdifferentiation arise?
In the late 1990s, sex-mismatched transplants and experiments with rodents revealed apparent transgressions of embryonic cell fates. Bone marrow cells could yield liver, muscle, neuron, and endothelium, while neurons could give rise to blood, and hepatocytes to pancreatic beta cells. Stem cells seemed to home in on injury sites, producing daughters that dedifferentiate and redifferentiate into exactly what is needed.

2. When did cell fusion enter the picture? Transdifferentiation was a logical conclusion based on phenotypes, but delving into DNA content and ploidy revealed another explanation for the apparently switching cell fates--merging genomes. In 2002, two groups showed bone marrow cells and neural stem cells, respectively, fusing with embryonic stem cells to yield embryonic stem-like cells, in mouse cell culture. Counting the chromosomes revealed that 2N had become 4N. A year later, scientists added the anticipated in vivo view: Hematopoietic stem cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies